{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:08:57Z","timestamp":1793239737049,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2025.103331","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T17:10:38Z","timestamp":1767028238000},"page":"103331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urine-based point-of-care detection of direct oral anticoagulant activity in acute stroke\u2014accuracy at anti-Xa thresholds relevant for intravenous thrombolysis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6020-8290","authenticated-orcid":false,"given":"Stefan T.","family":"Gerner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Braemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Juenemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Mrochen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"Olbricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma J.","family":"Diel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen B.","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alhaj Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103331_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-020-05777-3","article-title":"Comparative safety and effectiveness of direct-acting oral anticoagulants versus warfarin: a National cohort study of nursing home residents","volume":"35","author":"Alcusky","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rpth.2025.103331_bib2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103331_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ahj.2017.03.024","article-title":"Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation II (ORBIT-AF II)","volume":"189","author":"Steinberg","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.rpth.2025.103331_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/imj.14652","article-title":"Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants","volume":"50","author":"Valente","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.rpth.2025.103331_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jama.2022.0948","article-title":"Association of recent use of non-vitamin K antagonist oral anticoagulants with intracranial hemorrhage among patients with acute ischemic stroke treated with alteplase","volume":"327","author":"Kam","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103331_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25917","article-title":"Prior anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"89","author":"Meinel","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rpth.2025.103331_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/CIRCULATIONAHA.115.015484","article-title":"Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome","volume":"132","author":"Seiffge","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2025.103331_bib8","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.2012.6756","article-title":"Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator","volume":"307","author":"Xian","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103331_bib9","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103331_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/2396987321989865","article-title":"European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke","volume":"6","author":"Berge","year":"2021","journal-title":"European Stroke J"},{"key":"10.1016\/j.rpth.2025.103331_bib11","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1182\/blood-2018-04-791541","article-title":"Testing and monitoring direct oral anticoagulants","volume":"132","author":"Connors","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2025.103331_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cll.2024.04.014","article-title":"Assessing direct oral anticoagulants in the clinical laboratory","volume":"44","author":"Gosselin","year":"2024","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.rpth.2025.103331_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ana.25165","article-title":"Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage","volume":"83","author":"Seiffge","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rpth.2025.103331_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000502335","article-title":"Direct oral anticoagulant plasma levels for the management of acute ischemic stroke","volume":"48","author":"Marsch","year":"2019","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.rpth.2025.103331_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-0716-3175-1_23","article-title":"Ecarin-based methods for measuring thrombin inhibitors","volume":"2663","author":"Gosselin","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2025.103331_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-7196-1_18","article-title":"Measuring direct oral anticoagulants","volume":"1646","author":"Gosselin","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2025.103331_bib17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1055\/s-0042-1750327","article-title":"Performance of a qualitative point-of-care strip test to detect DOAC exposure at the emergency department: a cohort-type cross-sectional diagnostic accuracy study","volume":"122","author":"Merrelaar","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103331_bib18","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1161\/STROKEAHA.122.041555","article-title":"Assessment of direct oral anticoagulant status using the DOASENSE dipstick in thrombolysis eligible patients with stroke: proof-of-concept study","volume":"54","author":"Tan","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103331_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1330421","article-title":"Urine-based point-of-care testing for factor-Xa-inhibitors in acute ischemic stroke patients: a feasibility study","volume":"14","author":"Doeppner","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.rpth.2025.103331_bib20","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1055\/a-1753-2748","article-title":"DOAC dipstick testing can reliably exclude the presence of clinically relevant DOAC concentrations in circulation","volume":"122","author":"Margeti\u0107","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103331_bib21","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1001\/jama.2013.6959","article-title":"Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke","volume":"309","author":"Saver","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103331_bib22","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/STROKEAHA.123.044267","article-title":"Effect of time to thrombolysis on clinical outcomes in patients with acute ischemic stroke treated with tenecteplase compared to alteplase: analysis from the AcT randomized controlled trial","volume":"54","author":"Singh","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103331_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/STROKEAHA.118.023877","article-title":"Cerebral ischemia in patients on direct oral anticoagulants","volume":"50","author":"Macha","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2025.103331_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp-2020-325456","article-title":"Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"92","author":"Seiffge","year":"2021","journal-title":"J Neurol Neurosur Psychiatry"},{"key":"10.1016\/j.rpth.2025.103331_bib25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/medicina59071339","article-title":"Stability of direct oral anticoagulants concentrations in blood samples for accessibility expansion of chromogenic assays","volume":"59","author":"Gavrilova","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.rpth.2025.103331_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:52:22Z","timestamp":1778896342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925006557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2475037925006557"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103331","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine-based point-of-care detection of direct oral anticoagulant activity in acute stroke\u2014accuracy at anti-Xa thresholds relevant for intravenous thrombolysis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103331"}}